Premium
Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial
Author(s) -
Felix Ashley S.,
Weissfeld Joel L.,
Pfeiffer Ruth M.,
Modugno Francesmary,
Black Amanda,
Hill Lyndon M.,
Martin Jerry,
Sit Anita S.,
Sherman Mark E.,
Brinton Louise A.
Publication year - 2013
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.28404
Subject(s) - medicine , endometrial cancer , endometrium , gynecology , estrogen , carcinoma , relative risk , oncology , prostate , confidence interval , cancer
Postmenopausal women with higher circulating estrogen levels are at increased risk of developing breast and endometrial carcinomas. In the endometrium, excess estrogen relative to progesterone produces a net proliferative stimulus, which may result in endometrial thickening. Therefore, the hypothesis that endometrial thickness is a biological marker of excess estrogen stimulation that is associated with risk of breast and endometrial carcinomas was tested. Endometrial thickness was measured in 1,272 postmenopausal women, aged 55–74 years, who underwent transvaginal ultrasound (TVU) screening as part of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Serial endometrial thickness measurements were available for a subset of women at 1 year ( n = 1,018), 2 years ( n = 869) and 3 years ( n = 641) after baseline. The associations between endometrial thickness and breast ( n = 91) and endometrial ( n = 14) carcinoma were evaluated by estimating relative risks (RRs) and 95% confidence intervals (CIs) using Cox proportional hazards regression with age as the time metric. Models incorporating baseline endometrial thickness and as a time‐varying covariate using all measurements were examined. Median follow‐up among study participants was 12.5 years (range: 0.3–13.8 years). Compared to baseline endometrial thickness of 1.0–2.99 mm, women with baseline endometrial thickness greater than or equal to 5.0 mm had an increased risk of breast (RR = 2.00, 95% CI = 1.15–3.48) and endometrial (RR = 5.02, 95% CI = 0.96–26.36) carcinomas in models adjusted for menopausal hormone use and BMI. These data suggest that increased endometrial thickness as assessed by TVU was associated with increased risk of breast and endometrial carcinomas.